SHL Telemedicine (SHMLF) MD lists CHF stock option holdings

Rhea-AI Filing Summary

SHL Telemedicine Ltd executive Martin Alfred Bartetzko filed an initial Form 3 showing direct holdings of employee stock options over Ordinary Shares. The options are structured in eight tranches, each linked to 12,500 Ordinary Shares, with exercise prices in CHF of 2.75 or 3.25, exercisable between 2026 and 2029 and expiring in 2031.

Insider Trade Summary

8 transactions reported

Mixed 8 txns

Insider Bartetzko Martin Alfred

Role MD, SHL Telemedizin DE

Type	Security	Shares	Price	Value
holding	Option	--	--	--
holding	Option	--	--	--
holding	Option	--	--	--
holding	Option	--	--	--
holding	Option	--	--	--
holding	Option	--	--	--
holding	Option	--	--	--
holding	Option	--	--	--

Holdings After Transaction: Option — 12,500 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Underlying shares per option tranche: 12,500 shares Lower exercise price: CHF 2.75 Higher exercise price: CHF 3.25 +5 more

8 metrics

Underlying shares per option tranche 12,500 shares Each option position relates to 12,500 Ordinary Shares

Lower exercise price CHF 2.75 Exercise price in CHF for some option tranches

Higher exercise price CHF 3.25 Exercise price in CHF for other option tranches

First exercise date July 24, 2026 Earliest exercise date among reported options

Second exercise date July 24, 2027 Later exercise date for additional option tranches

Third exercise date July 24, 2028 Subsequent exercise date for further tranches

Fourth exercise date July 24, 2029 Final first-exercise date for the reported options

Option expiration date July 24, 2031 Common expiration date for all listed options

Key Terms

Option, Ordinary Shares, exercise price, expiration date

4 terms

Option financial

"security_title: "Option""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"The exercise price is in CHF"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date": "2031-07-24T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bartetzko Martin Alfred

(Last) (First) (Middle)

C/O SHL TELEMEDIZIN GMBH

BALANSTR. 69B

(Street)

MUNCHEN 81541

(City) (State) (Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SHL TELEMEDICINE LTD [ SHLT ]

3a. Foreign Trading Symbol
[SHLTN]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	MD, SHL Telemedizin DE

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option	07/24/2026	07/24/2031	Ordinary Shares	12,500	$3.25(1)	D
Option	07/24/2026	07/24/2031	Ordinary Shares	12,500	$2.75(1)	D
Option	07/24/2027	07/24/2031	Ordinary Shares	12,500	$3.25(1)	D
Option	07/24/2027	07/24/2031	Ordinary Shares	12,500	$2.75(1)	D
Option	07/24/2028	07/24/2031	Ordinary Shares	12,500	$3.25(1)	D
Option	07/24/2028	07/24/2031	Ordinary Shares	12,500	$2.75(1)	D
Option	07/24/2029	07/24/2031	Ordinary Shares	12,500	$3.25(1)	D
Option	07/24/2029	07/24/2031	Ordinary Shares	12,500	$2.75(1)	D

Explanation of Responses:

1. The exercise price is in CHF

Remarks:

This Form 3 is filed pursuant to the Holding Foreign Insiders Accountable Act (HFIAA), which extends Section 16(a) reporting obligations to directors and officers of Foreign Private Issuers effective March 18, 2026.

	/s/ Martin Bartetzko	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the SHL Telemedicine (SHMLF) Form 3 filing disclose for Bartetzko?

The Form 3 discloses that Martin Alfred Bartetzko holds employee stock options over SHL Telemedicine Ordinary Shares. These options are organized in eight tranches, each tied to 12,500 shares, with specified exercise prices and future exercise and expiration dates.

How many SHL Telemedicine (SHMLF) shares are covered by each option in the Form 3?

Each option entry in the Form 3 relates to 12,500 underlying SHL Telemedicine Ordinary Shares. There are eight such option positions listed, giving the executive multiple future opportunities to acquire shares if conditions for exercise are met.

What are the exercise prices for the SHL Telemedicine (SHMLF) options reported?

The options reported for SHL Telemedicine have exercise prices in CHF of 2.75 and 3.25 per share. These prices are fixed strike levels at which the holder may buy Ordinary Shares during the option term, if the options are exercised.

When can the SHL Telemedicine (SHMLF) options reported on Form 3 be exercised?

The options become exercisable on several future dates: July 24, 2026, July 24, 2027, July 24, 2028, and July 24, 2029. Each tranche has its own first exercise date, creating a staggered vesting-like schedule over four years.

When do the SHL Telemedicine (SHMLF) options disclosed on Form 3 expire?

All of the option positions reported share a common expiration date of July 24, 2031. After this expiration date, any unexercised options lapse and no longer provide the right to acquire SHL Telemedicine Ordinary Shares at the stated exercise prices.